Opublikowane badania

Karakus N, Yigit S, Kocak M, Bozkurt N, Duygu F. Impact of methylene-tetrahydrofolate reductase gene C677T and A1298C polymorphisms as a risk factor for hepatitis B virus infection. Nucleosides Nucleotides Nucleic Acids. 2023;42(9):683-695. doi: 10.1080/15257770.2023.2187061. Epub 2023 Mar 15. PMID: 36919686.

DOI PubMed

Aytekin FY, Barut HŞ, Rüstemoğlu A, Atay A, Günal Ö, Duygu F. Factors related to fatalities and clinical progression of Crimean-Congo hemorrhagic fever patients and the effects of IL 28-B gene polymorphism. Arch Virol. 2019 Feb;164(2):547-557. doi: 10.1007/s00705-018-4106-1. Epub 2018 Nov 26. PubMed PMID: 30478788.

DOI PubMed

Duygu F, Sari T, Kaya T, Tavsan O, Naci M. The Relationship Between Crimean-Congo Hemorrhagic Fever And Climate: Does Climate Affect The Number Of Patients? Acta Clin Croat. 2018 Sep;57(3):443-448. Doi: 10.20471/Acc.2018.57.03.06. Pubmed Pmid: 31168176; Pubmed Central Pmcıd: Pmc6536269.

DOI PubMed

Duygu F, Sari T, Celik H. Effects of platelet function on the haemorrhagic manifestations and mortality in Crimean-Congo haemorrhagic fever. Infez Med. 2018 Dec 1;26(4):341-346. PubMed PMID: 30555138.

PubMed

Duygu F, Sari T, Gunal O, Barut S, Atay A, Aytekin F. Cutaneous Findings of Crimean-Congo Haemorrhagic Fever: A Study of 269 Cases. Jpn J Infect Dis. 2018 Jun 29. doi: 10.7883/yoken.JJID.2018.005.

DOI

Barut S, Gemici Ü, Güneş F, Demir O, Duygu F. Predictors of histological indication for treatment in HBeAg negative chronic HBV infection. J Med Virol. 2017 Jun 15. doi: 10.1002/jmv.24879.

DOI

Duygu F, Sari T, Kaya T, Bulut N. Brucellosis in Patients with Crimean-Congo Hemorrhagic Fever. J Arthropod Borne Dis. 2017 Dec 30;11(4):463-468. eCollection 2017 Dec.

Z Özmen, E Albayrak, ZC Özmen, F Aktaş, T Aktas, F Duygu. The evaluation of abdominal findings in Crimean-Congo hemorrhagic fever. Abdominal Radiology 2016; 41 (2), 384-390

I Butun, S Sahin, F Duygu. Evaluation of some thymus proteins in patients with Crimean Congo hemorrhagic fever. Febs Journal 2016;283, 219-219.

Ceken S, İskender G, Ogan MC, Yenigun A, Duygu F. Leuconostoc Pseudomesenteroides Bacteremiae In A Patient With Malignancy: A Case Presentation. Mediterr J Infect Microb Antimicrob 2015;4:6 DOI: 10.4274/mjima.2015.6

DOI

Günal O, Barut S, Ayan M, Kılıç S, Duygu F. Investigation of Coxiella burnetii and Brucella seropositivities in patients presenting with acute fever. Mikrobiyol Bul. 2013 Apr;47(2):265-72.

Duygu F, Aksoy N, Cicek Copur A, Butun I, Unlu S. Does Prolidase Indicate Worsening Of Hepatitis B Infection. J Clin Lab Anal. 2013 Sep;27(5):398-401. doi: 10.1002/jcla.21617

DOI

Duygu F, Karsen H, Aksoy N, Taskin A. Relationship of Oxidative Stress in Various Forms of Hepatitis B Infection with DNA and Fibrosis. Ann Lab Med 2012; Mar;32(2):113-118. DOI: 10.3343/alm.2012.32.2.113.

DOI

Karsen H, Koruk ST, Calisir C, Karagac L, Duygu F. A case of brucellosis complicated with fatal capillary leak syndrome. Bratisl Lek Listy. 2012;113(8):511-3. DOI:10.4149/BLL_2012_115

DOI

Koc S, Uysal IO, Uysal EB, Yenişehirli G, Duygu F. The comparison of bacteremia and amount of bleeding during septoplasty. Eur Arch Otorhinolaryngol 2012;269:1139–1142 DOI: 10.1007/s00405-011-1789-2.

DOI

Çiçek AÇ, Duygu F. Investigation of Toxoplasma gondii antibodies with ELISA among women of childbearing age in Şanlıurfa province: A three years evaluation. Dicle Med J 2012;39(2): 174-178. doi:10.5798/diclemedj.0921.2012.02.0122

DOI

Duygu F, Koruk ST, Aksoy N, Taskin A, Hamidanoglu M. Prolidase and oxidative stress in chronic hepatitis C. J Clin Lab Anal. 2012 Jul;26(4):232-7. doi: 10.1002/jcla.21510.

DOI

Duygu F, Koruk ST, Aksoy N. Serum paraoxonase and arylesterase activities in various forms of hepatitis B virus infection. J Clin Lab Anal. 2011;25(5):311-6.

Duygu F, Kaya T. Is Blood Type Associated with Mortality In Crimean-Congo Haemorrhagic Fever? Journal of Microbiology and Infectious Diseases 2011; 1 (3): 118-121. doi: 10.1089/vbz.2011.0694.

DOI

Duygu F, Kaya T, Baysan P. Re-Evaluation of 400 Crimean-CongoHemorrhagic Fever Cases in an Endemic Area: Is Ribavirin Treatment Suitable? Vector Borne Zoonotic Dis. 2011 Oct 18. DOI: 10.1089/vbz.2011.0694.

DOI

Kuzi S, Duygu F, Sencan I. Investigation of Influenza Cases and Risk Factors Associated with Fatality in Türkiye. Sisli Etfal Hastan Tip Bul. 2025 Mar 18;59(1):50-58. doi: 10.14744/SEMB.2024.64614. PMID: 40226551; PMCID: PMC11983025.

DOI PubMed

Sarıgül Yıldırım F, Üser Ü, Sarı ND, Kurtaran B, Önlen Y, Şenateş E, Gündüz A, Zerdali E, Karsen H, Batırel A, Karaali R, Güner R, Yamazhan T, Köse Ş, Erben N, İnce N, Köksal İ, Çuvalcı Öztoprak N, Yörük G, Kömür S, Bal T, Kaya S, Bozkurt İ, Günal Ö, Yıldız İE, İnan D, Barut Ş, Namıduru M, Tosun S, Türker K, Şener A, Hızel K, Baykam N, Duygu F, Bodur H, Can G, Gül HC, Sağmak Tartar A, Çelebi G, Sünnetçioğlu M, Karabay O, Kumbasar Karaosmanoğlu H, Sırmatel F, Tabak F. In a Real-Life Setting, Direct-Acting Antivirals to People Who Inject Drugs with Chronic Hepatitis C in Turkey. Turk J Gastroenterol. 2022 Nov;33(11):971-978. doi: 10.5152/tjg.2022.21834. PMID: 36415900; PMCID: PMC9797763.

DOI PubMed

Cag Y, Erdem H, Gunduz M, Komur S, Ankarali H, Ural S, Tasbakan M, Tattevin P, Tombak A, Ozturk-Engin D, Tartar AS, Batirel A, Tekin R, Duygu F, Caskurlu H, Kurtaran B, Durdu B, Haciseyitoglu D, Rello J; ID-IRI Mucormycosis Study Group. Survival in rhino-orbito-cerebral mucormycosis: An international, multicenter ID-IRI study. Eur J Intern Med. 2022 Jun;100:56- 61. doi: 10.1016/j.ejim.2022.03.008. Epub 2022 Mar 15. PMID: 35304041.

DOI PubMed

Karakus N, Duygu F, Rustemoglu A, Yigit S. Methylene-tetrahydrofolate reductase gene C677T and A1298C polymorphisms as a risk factor for Crimean-Congo hemorrhagic fever. Nucleosides Nucleotides Nucleic Acids. 2022;41(9):878-890. doi: 10.1080/15257770.2022.2085296. Epub 2022 Jun 6. Erratum in: Nucleosides Nucleotides Nucleic Acids. 2022;41(11):1263-1264. doi: 10.1080/15257770.2022.2101280. PMID: 35666819.

DOI PubMed

Önlen Y, Bal T, Çabalak M, Çuvalcı Öztoprak N, Sarı ND, Kurtaran B, Şenateş E, Gündüz A, Zerdali E, Karsen H, Batırel A, Karaali R, Güner R, Yamazhan T, Köse Ş, Erben N, İnce N, Köksal İ, Sarıgül Yıldırım F, Yörük G, Kömür S, Kaya S, Esen Ş, Günal Ö, Esen Yıldız İ, İnan D, Barut Ş, Namıduru M, Tosun S, Türker K, Şener A, Hızel K, Baykam N, Duygu F, Akıncı E, Can G, User Ü, Gül HC, Akbulut A, Çelebi G, Sünnetçioğlu M, Karabay O, Kumbasar Karaosmanoğlu H, Sırmatel F, Tabak F. Efficacy and Safety of Direct-Acting Antivirals in Elderly Patients with Chronic Hepatitis C: A Nationwide Real-Life, Observational, Multicenter Study from Turkey. Turk J Gastroenterol. 2022 Oct;33(10):862-873. doi: 10.5152/tjg.2022.21271. PMID: 35946896; PMCID: PMC9623221.

DOI PubMed

Çıtıl R, Egri M, Onder Y, Duygu F, Bulut YE, Yasayancan Ö, Yıldız Çeltek N, Sahin S. Determination of Seroprevalence and Risk Factors of Crimean–Congo Haemorrhagic Fever (CCHF) in the Endemic Region in Turkey: A Population-Based Cross-Sectional Study. Journal of Tropical Medicine 2021(11):1-10. DOI: 10.1155/2021/9945089

DOI

Carolin E. M. Jakob, Stefan Borgmann, Fazilet Duygu, Uta Behrends, Martin Hower, Uta Merle et all. First results of the “Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)” Infection 2020 Oct 1;1-11. doi: 10.1007/s15010-020-01499-0

DOI

Erdem H, Cag Y, Gencer S, Uysal S, Karakurt Z, Harman R, Aslan E, Mutlu-Yilmaz, E, Karabay O, Uygun Y, Ulug M, Tosun S, Dogru A, Sener A, Dogan M, Hasbun R, Durmus G, Turan H, Batirel A, Duygu F, Inan A, Akkoyunlu Y, Celebi G, Ersoz G, Guven T, Dagli O, Guler S, Meric-Koc M, Oncu S, Rello J. Treatment of ventilator-associated pneumonia (VAP) caused by Acinetobacter: results of prospective and multicenter ID-IRI study. Eur J Clin Microbiol Infect Dis. 2020 Jan;39(1):45-52. doi: 10.1007/s10096-019-03691-z. Epub 2019 Sep 9. PubMed PMID: 31502120.

DOI PubMed

Mert D, Ceken S, Iskender G, Iskender D, Merdin A, Duygu F, Ertek M, Altuntas F. Epidemiology and mortality in bacterial bloodstream infections in patients with hematologic malignancies. J Infect Dev Ctries. 2019 Aug 31;13(8):727-735. doi: 10.3855/jidc.11457. PubMed PMID: 32069257.

DOI PubMed

Karakus N, Yigit S, Duygu F, Barut S, Rustemoglu A, Basol N. Effects of Paraoxonase-1 variants on course of severity and mortality of Crimean-Congo hemorrhagic fever. Gene. 2019 Mar 1;687:188-192. doi: 10.1016/j.gene.2018.11.059.

DOI

Çeken S, İskender G, Gedik H, Duygu F, Mert D, Kaya AH, Altuntaş F, Ertek M. Risk factors for bloodstream infections due to extended-spectrum β-lactamase producing Enterobacteriaceae in cancer patients journal of Infection in Developing Countries Vol 12 No 04: April 2018

K Aytekin, Ş Direkel, B Kır, M Uysal, FY Aytekin, F Duygu, C Zeki. Efficacy of the use of sterile plastic to cover the surgical field against infection in orthopedic operations. J Contemp Med 2018; 8, 1.

Rustemoglu A, Ekinci D, Nursal AF, Barut S, Duygu F, Günal Ö. The possible role of CCR5Δ32 mutation in Crimean-Congo hemorrhagic fever infection. J Med Virol. 2017 Oct;89(10):1714- 1719. doi: 10.1002/jmv.24865

DOI

Fletcher TE, Gulzhan A, Ahmeti S, Al-Abri SS, Asik Z, Atilla A, Beeching NJ, Bilek H, Bozkurt I, Christova I, Duygu F, Esen S, Khanna A, Kader Ç, Mardani M, Mahmood F, Mamuchishvili N, Pshenichnaya N, Sunbul M, Yalcin TY, Leblebicioglu H. Infection prevention and control practice for Crimean-Congo hemorrhagic fever-A multi-center cross-sectional survey in Eurasia. PLoS One. 2017 Sep 8;12(9):e0182315. doi: 10.1371/journal.pone.0182315. eCollection 2017.

DOI

Aktaş F, Özmen Z, Altunkaş A, Albayrak E, Duygu F, Demir O, Özmen ZC. Is hemorrhage the reason in crimean-congo hemorrhagic fever patients with neurological signs and symptomsa. Niger J Clin Pract. 2017 Oct;20(10):1294-1301. doi: 10.4103/njcp.njcp_443_16.

DOI

D Aksoy, H Barut, F Duygu, B Çevik, S Kurt, O Sümbül. Characteristics of headache and its relationship to disease severity in patients with Crimean-Congo hemorrhagic fever. The Journal of The Turkish Society of Algology, 2017; 30 (1),1

Kaya AH, Tekgündüz E, Duygu F, İskender D, Bekdemir F, Batgi H, Ulu BU, Yiğenoğlu TN, Altuntas F. Risk adapted management of febrile neutrepenia in hematopoietic stem cell transplantation setting: Is it time for early cessation of empirical antibiotherapy? Balkan Med J. 2017 Apr 5;34(2):132-139. doi: 10.4274/balkanmedj.2016.0012.

DOI

Hatipoglu M, Mutluoglu M, Turhan V, Uzun G, Lipsky BA; Turk-Day Study Group., Sevim E, Demiraslan H, Eryilmaz E, Ozuguz C, Memis A, Ay H, Arda B, Uysal S, Motor VK, Kader C, Erturk A, Coskun O, Duygu F, Guler S, Altay FA, Ogutlu A, Bolukcu S, Yildiz S, Kandemir O, Aslaner H, Polat A, Karahocagil MK, Yasar KK, Sehmen E, Kilic S, Sunbul M, Gencer S, Bozkurt F, Yanik T, Oztoprak N, Batirel A, Sozen H, Kilic I, Celik I, Ay B, Tosun S, Kadanali A, Çomoglu S, Denk A, Hosoglu S, Aydin O, Elaldi N, Akalin S, Kandemir B. Causative pathogens and antibiotic resistance in diabetic foot infections: A prospective multi-center study. Akbulut A, Demirdal T, Balik R, Azak E, Sengoz G. J Diabetes Complications. 2016 Jul;30(5):910-6. doi: 10.1016/j.jdiacomp.2016.02.013.

DOI

FY Aytekin, S Barut, A Rustemoglu, O Gunal, F Duygu, AD Yalcin. The relationship between Crimean-Congo hemorrhagic fever virus and IL-28B gene polymorphism. Allergy 2016; 71, 151- 151

Gunal O, Yigit S, Yalcın AD, Celik B, Barut S, Demir O, Ates O, Duygu F, Kaya S, Rustemoglu A, Sezer O. The IL4-VNTR P1 allele, IL4-VNTR P2P2 genotype and IL4-VNTR_IL6-174CG P2P1-GG genotype are susceptable with a increased risk in Brucelosis. Jpn J Infect Dis. 2016 May 9.

Leblebicioglu H, Sunbul M, Guner R, Bodur H, Bulut C, Duygu F, Elaldi N, Cicek Senturk G, Ozkurt Z, Yilmaz G, Fletcher TE, Beeching NJ. Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002-2014: a multicentre retrospective cross-sectional study. Clin Microbiol Infect. 2016 Apr;22(4):387.e1-4. doi: 10.1016/j.cmi.2015.11.024.

DOI

Tufan ZK, Eser FC, Vudali E, Batirel A, Kayaaslan B, Bastug AT, Eray D, Turhan V, Duygu F, Tok D, Altun S, Bulut C, Tasyaran MA. The Knowledge of the Physicians about Sepsis Bundles is Suboptimal: A Multicenter Survey. J Clin Diagn Res. 2015 Jul;9(7):OC13-6. doi: 10.7860/JCDR/2015/12954.6220. Epub 2015 Jul 1.

DOI

Gul S, Kuscu F, Aydemir H, Ozturk DB, Deveci O, Duygu F, Kacmaz B, Yaman F, Aslan E. Risk factors for colistin-associated acute kidney injury: a multicenter study from Turkey. Jpn J Infect Dis. 2015 Jul 10.

Leblebicioglu H, Erben N, Rosenthal VD, Sener A, Uzun C, Senol G, Ersoz G, Demirdal T, Duygu F et al. Surgical site infection rates in 16 cities in Turkey: findings of the International Nosocomial Infection Control Consortium (INICC). Am J Infect Control. 2015 Jan 1;43(1):48-52. doi: 10.1016/j.ajic.2014.09.017.

DOI

Ilker Inanc Balkan, Ayse Batirel, Oguz Karabay, Canan Agalar, Serife Akalin, Ozlem Alici, Emine Alp, Fatma Aybala Altay, Nilgun Altin, Ferhat Arslan, Turan Aslan, Nural Bekiroglu, Salih Cesur, Aygul Dogan Celik, Mustafa Dogan, Bulent Durdu, Fazilet Duygu et al. Comparison of colistin monotherapy and non-colistin combinations in the treatment of multi-drug resistant Acinetobacter spp. bloodstream infections: A Multicenter retrospective analysis. Indian J Pharmacol. 2015 Jan-Feb;47(1):95-100. doi: 10.4103/0253-7613.150383

DOI

Sunbul M, Leblebicioglu H, Fletcher TE, Elaldi N, Ozkurt Z, Bastug A, Yilmaz G, Guner R, Duygu F, Beeching NJ. Crimean-Congo haemorrhagic fever and secondary bacteraemia in Turkey. J Infect. 2015 Jul 18. pii: S0163-4453(15)00226-1. doi: 10.1016/j.jinf.2015.07.003.

DOI

Ozturk-Engin D, Erdem H, Gencer S, Kaya S, Baran AI, Batirel A, Tekin R, Celen MK, Denk A, Guler S, Ulug M, Turan H, Pekok AU, Mermut G, Kaya S, Tasbakan M, Tulek N, Cag Y, Inan A, Yalci A, Ataman-Hatipoglu C, Gonen I, Dogan-Celik A, Bozkurt F, Gulsun S, Sunnetcioglu M, Guven T, Duygu F, Parlak E, Sozen H, Tosun S, Demirdal T, Guclu E, Karabay O, Uzun N, Gunal O, Diktas H, Haykir-Solay A, Erbay A, Kader C, Aydin O, Erdem A, Elaldi N, Kadanali A, Yulugkural Z, Gorenek L, Altındis M, Bolukcu S, Agalar C, Ormeci N. Liver involvement in patients with brucellosis: results of the Marmara study. Eur J Clin Microbiol Infect Dis. 2014 Jul;33(7):1253- 62. doi: 10.1007/s10096-014-2064-4.

DOI

Erdem H, Ozturk-Engin D, Yesilyurt M, Karabay O, Elaldi N, Celebi G, Korkmaz N, Guven T, Sumer S, Tulek N, Ural O, Yilmaz G, Erdinc S, Nayman-Alpat S, Sehmen E, Kader C, Sari N, Engin A, Cicek- Senturk G, Ertem-Tuncer G, Gulen G, Duygu F et al. Evaluation of tularaemia courses: a multicentre study from Turkey. Clin Microbiol Infect. 2014 Dec;20(12):O1042-51. doi: 10.1111/1469-0691.12741. Epub 2014 Aug 13.

DOI

Erdem H, Elaldi N, Ak O, Gulsun S, Tekin R, Ulug M, Duygu F, Sunnetcioglu M et al. Genitourinary brucellosis: results of a multicentric study. Clin Microbiol Infect. 2014 Nov;20(11):O847-53. doi: 10.1111/1469-0691.12680. Epub 2014 Jul 12.

DOI

A. Ulu-Kilic, A. Karakas, H. Erdem, T. Turker, A. S. Inal, O. Ak, H. Turan, E. Kazak, A. Inan, F. Duygu, H. Demiraslan, C. Kader, A. Sener, S. Dayan, O. Deveci, R. Tekin, N. Saltoglu, M. Aydın, E. S. Horasan, H. C. Gul, B. Ceylan,A. Kadanalı, O. Karabay, G. Karagoz, U. Kayabas, V. Turhan, D. Engin, S. Gulsun, N. Elaldı and S. Alabay. Update on Treatment Options for Spinal Brucellosis. Clin Microbiol Infect. 2014 Feb;20(2):O75-82. doi: 10.1111/1469-0691.12351.

DOI

Gunal O, Barut Ş, Sogut E, Duygu F, Etikan I, Parlak E, Atay A. Neopterin, Procalcitonin, High- sensitivity C-Reactive Protein Concentrations and Erythrocyte Sedimentation Rates of Patients with Brucellosis and Extracellular Bacterial Infections. Turkish Journal of Biochemistry. 2014; 39 (1); 37–42. doi: 10.5505/tjb.2014.72602

DOI

Günal O, Barut S, Etikan İ, Duygu F, Tuncel U, Sünbül M. Relation Between Serum Quantitative HBsAg, ALT and HBV DNA Levels In HBeAg Negative Chronic HBV Infection. The Turkish Journal of Gastroenterology. Turk J Gastroenterol. 2014 Dec;25 Suppl 1:142-6. doi: 10.5152/tjg.2014.5711.

DOI

Kalkan G, Seçkin HY, Duygu F, Akbaş A, Ozyurt H, Sahin M. Oxidative stress status in patients with acute urticaria. Cutaneous and Ocular Toxicology 2013 Jul 10. [Epub ahead of printa]

Başol N, Duygu F, Ayan M. Detailed Evaluation of Patients Admitted to Emergency Department with Tick Bite Complaint. Medicina (Kaunas). 2013;49(8):367-71.

Pancar GS, Duygu F, Kalkan G. The prognostic role of the new entity butterfly-like facial rash and cutaneous findings in patients with crimean congo haemorrhagic fever. Journal of the European Academy of Dermatology and Venereology. 21 Mar 2013 DOI: 10.1111/jdv.12145

DOI

Hakan Erdem, Asuman Inan, Nazif Elaldi, Recep Tekin, Serda Gulsun, Cigdem Ataman- Hatipoglu, Nicholas Beeching, Özcan Deveci, Aysun Yalci, Sibel Bolukcu, Ozgur Dagli, Abdullah Umut Pekok, Ibrahim Erayman, Figen Kaptan, Selcuk Kaya, Aykut Cilli, Ayşe Batirel, Behice Kurtaran, Mehmet Ulug, Bilgehan Aygen, Mehmet Cabalak, Birsen Cetin, Gonul Cicek-Senturk, Fazilet Duygu et al. Respiratory System Involvement In Brucellosıs: The Results Of The Kardelen Study. Chest. 2013 Aug 1. doi: 10.1378/chest.13-0240.

DOI

Rosenthal VD, Richtmann R, Singh S, Apisarnthanarak A, Kübler A, Viet-Hung N, Ramírez-Wong FM, Portillo-Gallo JH, Toscani J, Gikas A, Dueñas L, El-Kholy A, Ghazal S, Fisher D, Mitrev Z, Gamar-Elanbya MO, Kanj SS, Arreza-Galapia Y, Leblebicioglu H, Hlinková S, Memon BA, Guanche-Garcell H, Gurskis V, Alvarez-Moreno C, Barkat A, Mejía N, Rojas-Bonilla M, Ristic G, Raka L, Yuet-Meng C; International Nosocomial Infection Control Consortiuma. Surgical site infections, International Nosocomial Infection Control Consortium (INICC) report, data summary of 30 countries, 2005-2010. Infect Control Hosp Epidemiol. 2013 Jun;34(6):597-604. doi: 10.1086/670626.

DOI

H Karsen, F Duygu, K Yapıcı, Aİ Baran, H Taskıran, İ Binici. Severe Thrombocytopenia and Hemorrhagic Diathesis due to Brucellosis. Arch Iran Med. 2012 May;15(5):303-6.

Karsen H, Tekin Koruk S, Duygu F, Yapici K, Kati M. Review of 17 cases of neurobrucellosis: clinical manifestations, diagnosis, and management. Arch Iran Med. 2012 Aug;15(8):491-4.

Koc S, Sogut E, Duygu F, Gurbuzler L, Eyibilen A, Aladag I. Evaluation of oxidative stress in patients with tularemia. African Journal of Microbiology Research 2012; 6(24):121-125. DOI: 10.5897/AJMR11.1007

DOI

Koç S, Duygu F, Söğüt E, Gürbüzler L, Eyibilen A, Aladağ I. Clinical and laboratory findings of tularemia: a retrospective analysis. Kulak Burun Boğaz Ihtis Derg. 2012;22(1):26-31. doi: 10.5606/kbbihtisas.2012.005.

DOI

Koc S, Aksoy N, Bilinc H, Duygu F, IO Uysal, A Ekinci. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with chronic adenotonsillitis. Int J Pediatr Otorhinolaryngol. 2011 Nov;75(11):1364-7. Epub 2011 Sep 3. DOI: 10.1016/j.ijporl.2011.07.017

DOI

Koç S, Duygu F, Eyibilen A, Aksoy N, Taskin A, Bilinc H. The role of Paraoxanase-1 in the development of acute otitis media. Journal of Clinical and Experimental Investigations. 2011; 2(4):412-415 doi: 10.5799/ahinjs.01.2011.04.0083

DOI

Karsen H, Sökmen N, Duygu F, Binici İ. The false sero-negativeness of brucella standart agglutination test: Prozone phenomenon. J Microbiol Infect Dis 2011;1 (3); 110-113 doi: 10.5799

Albayrak E, Duygu F, Demir O. Is hemorrhage the reason in crimean-congo hemorrhagic fever patients with neurological signs and symptomsa. Nigerian journal of clinical practice 20 (10), 1294-1294

Batirel A, Balkan II, Karabay O, Agalar C, Akalin S, Alici O, Alp E, Altay FA, Altin N, Arslan F, Aslan T, Bekiroglu N, Cesur S, Celik AD, Dogan M, Durdu B, Duygu F, Engin A, Engin DO, Gonen I, Guclu E, Guven T, Hatipoglu CA, Hosoglu S, Karahocagil MK, Kilic AU, Ormen B, Ozdemir D, Ozer S, Oztoprak N, Sezak N, Turhan V, Turker N, Yilmaz H. Comparison of Colistin-Carbapenem, Colistin-Sulbactam and Colistin-Other Antibacterial Agents for Treatment of Extremely drug- resistant Acinetobacter baumannii Bloodstream Infections. Eur J Clin Microbiol Infect Dis DOI 10.1007/s10096-014-2070-6

Basol N, Duygu F, Gökbakan AM, Alatli T. Anxiety experienced in the fear of disease: Tick bite and crimean-congo hemorrhagic fever. Acta Medica Mediterranea 30, 691-696

Mert D, Iskender G, Duygu F, Merdin A, Dal Mehmet S, Dogan M, Tekgündüz E,Ertek M, Altuntaş F. Invasive Aspergillosis with Disseminated Skin Involvement in a Patient with Acute Myeloid Leukemia: A Rare Case. Hematol Rep. 2017 Jun 1;9(2):6997. doi: 10.4081/hr.2017.6997. eCollection 2017 Jun 1. PubMed PMID:28626542; PubMed Central PMCID: PMC5472346.

DOI PubMed

Ceken S, İskender G, Ogan MC, Duygu F, Ertek M. Thyroiditis During Pegylated Interferon Therapy and HbsAg Seroconvertion after the Treatment. Acta Onkologica Turcica 2016;49(3):212-215 DOI: 10.5505/aot.2016.89421

DOI

Kalkan G, Duygu F, Bas Y. Greenish-blue staining of underclothing due to Pseudomonas aeruginosa infection of intertriginous dermatitis. J Pak Med Assoc. 2013 Sep;63(9):1192-4.

Duygu F, Balci PO, Solmaz M, Sefa Ucar N. Meningitis Associated With Vancomycin Resistant Enterococcus casseliflavus: First Report. Journal of Microbiology and Infectious Diseases 2011; 1 (3): 138-140. doi: 10.5799

Koruk ST, Duygu F, Gursoy B, Karaagac L, Bayraktar M. A Rare Case of Seronegative Neurobrucellosis. Ann Saudi Med. 2010 Sep-Oct;30(5):412-4.

Duygu F. Syrian Children’s Health in Turkey (Türkiye’de doğan Suriyeli çocuklar ve sağlık) SD Medical Journal. 2016;40:40-41

İskender G, Çeken S, Oğan MC, Gedik H, Duygu F, Ertek M. Invasive Device Related Nosocomial Infections in Adult Intensive Care Unit of an Oncology Hospital: Evaluation of Five Years. 2016;49(1):27-34. DOI 10.5505/aot.2016.48030

Duygu F, Uçar H, Balcı PÖ, Solmaz M. Evaluation of Literature on Account of a Vancomycin Resistant Enterococcus Outbreak, and New Practices, Turkish Journal of Hospital Infection 2012;16(4):183-189.

Koç S, Duygu F, İbrahim Aladağ. Specific Diseases of the Oropharynx. Turkiye Klinikleri J E.N.T.- Special Topics. 2012;5(4):70-4

Karsen H, Duygu F, Geylan H, Demirtas M, Sunnetcioglu M, Satici A. Eyelids Involvement of Cutaneous Anthrax. Turkiye Klinikleri J Ophthalmol. 2011;20(3):141-4.

Çiçek A, Duygu F, Mızraklı A. Evaluation of parasitological examination of stools in the Microbiology Laboratory of the Sanliurfa Education and Research Hospital. Harran University Medical Journal. 2011 8(1):22-24

Koruk ST, Duygu F, Karaağaç L, Koruk İ, Çakmak A, Sırmatel F. The Evaluation of the Characteristics of the Children Followed with the Diagnosis of Chronic Hepatitis B in Harran University Research Hospital. Journal of viral hepatitis. 2010;16(3): 87-92.

Duygu F, Koruk ST, Gürsoy B, Yıldız S, Bayraktar M. Bölgemizde sık görülen bir hastalığın nadir klinik formu: Nörobruselloz- Olgu sunumu. Harran Üniversitesi Tıp Fakültesi Dergisi, 2009; Cilt 6, Sayı 2 13-14.

Sırmatel F, Duygu F, Hakim Çelik, Şahabettin Selek, Öcal Sırmatel, Bensu Gürsoy, Fatma Eriş. Evaluation of Total Oxidative Level and Total Antioxidant Capacity in Cases with Chronic Viral Hepatitis. Klimik Journal 2009; 22(3): 92-6.

Koruk ST, Koruk I, Şahin M, Duygu F. Evaluation of HBsAg, Anti-HBs and Anti-HCV Positivity and Risk Factors Among Oral and Dental Health Workers in Şanliurfa. Klimik Journal 2009; 22(2):55-61